Skip to main content
. 2017 Jan 19;7:10. doi: 10.1186/s13613-017-0234-0

Table 1.

Patients’ characteristics at the inclusion

Characteristics All patients
N = 119
Center 1 (cisatracurium use)
N = 97
Center 2 (atracurium use)
N = 22
Age (years) 62 (52–73) 62 (51–72) 63 (52–73)
Male [n (%)] 78 (66) 61 (63) 17 (77)
Body mass index (kg/m2) 25.5 (23.4–29.6) 25.3 (23.1–29.6) 26.6 (23.7–32.2)
SAPS II (points) 51 (40–62) 50 (40–62) 51 (44–60)
SOFA (points) 9 (6–12) 9 (7–12) 9 (6–12)
Length of stay before ICU (days) 1 (0–4) 1 (0–4) 1 (0–3)
Main reason for ICU admission [n (%)]
 Medical 111 (93) 93 (96) 18 (82)*
 Surgical 8 (7) 4 (4) 4 (18)
Main reason for neuromuscular blockade [n (%)]
 ARDS 94 (79) 78 (80) 16 (73)*
 Exacerbations of COPD 7 (6) 5 (5) 2 (9)
 Status asthmaticus 3 (3) 3 (3) 0
 Other respiratory failures 6 (5) 5 (5) 1 (4.5)
 Abdominal compartment syndromes 5 (4) 2 (2) 3 (13.5)
 Miscellaneous 4 (3) 4 (4) 0
Main comorbidities [n (%)]
 Diabetes 16 (13) 14 (14) 2 (9)
 Renal disease 8 (7) 7 (7) 1 (5)
 Cirrhosis 16 (13) 14 (14) 2 (9)
 Corticosteroid treatment 12 (10) 11 (11) 1 (5)
Sepsis [n (%)] 85 (71) 68 (70) 17 (77)
Catecholamines [n (%)] 78 (66) 62 (64) 16 (73)
Renal replacement therapy [n (%)] 9 (8) 6 (6) 3 (14)

Continuous variables are reported as medians and interquartile ranges (25th–75th percentiles), and categorical variables as numbers and percentages

SAPS II Simplified Acute Physiologic Score II, SOFA Sequential Organ Failure Assessment, ICU intensive care unit, ARDS acute respiratory distress syndrome, COPD chronic obstructive pulmonary disease

p < 0.05 center 1 versus center 2